Metformin Teva

Metformin Hydrochloride, the active ingredient in Metformin Teva, is a biguanide presented as an oral tablet for oral use. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus. The medication works by reducing hepatic glucose production and improving peripheral insulin sensitivity, helping to achieve better glycaemic control.

GNH USA supplies Metformin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures product quality through rigorous testing and adherence to global regulatory standards.

Metformin Teva, a biguanide antidiabetic, is employed in the management of glucose metabolism disorders.

- Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels. - Prediabetes (impaired fasting glucose): reduces the risk of progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: may improve insulin resistance and assist in menstrual regularity.

Metformin Teva may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset (nausea, abdominal discomfort) - Diarrhea - Metallic taste

Serious or Rare Side Effects: - Lactic acidosis (potentially fatal) - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction

When prescribing Metformin Teva, clinicians should consider several safety measures.

- Renal function: assess creatinine clearance before initiating therapy. - Hepatic function: monitor liver enzymes in patients with liver disease. - Age: start with a lower dose in elderly patients. - Concomitant medications: review for drugs that may increase risk of lactic acidosis. - Contraindications: avoid in patients with known hypersensitivity to metformin. - Store at room temperature: keep in original container, protect from moisture.

Metformin Teva can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - Iodinated contrast agents (risk of renal impairment). - Cimetidine (increases metformin plasma levels). - Alcohol abuse (enhances risk of lactic acidosis).

Moderate Interactions (Monitor Closely): - Beta‑blockers (may mask hypoglycaemia symptoms). - Diuretics (affect renal clearance). - NSAIDs (reduce renal perfusion).